Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation

NCT02123108 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Basiliximab
DRUG: Tacrolimus
DRUG: Tacrolimus
DRUG: Mycophenolic Acid

Sponsor

University of California, Los Angeles

Collaborators

[object Object]